Melanie Daniel: A Landmark Session on Hemophilia and Rare Bleeding Disorders at the National Academy of Medicine
Melanie Daniel, Physician at Lille University Hospital, shared on LinkedIn:
”A landmark session on hemophilia and rare bleeding disorders at the National Academy of Medicine
Last week, the National Academy of Medicine hosted an outstanding public session dedicated to hemophilia and other rare bleeding disorders, bringing together clinical, translational, and therapeutic perspectives on a rapidly evolving field.
The session showcased major advances in patient management, innovative biology, gene therapy, and progress in rare disorders of hemostasis.
Scientific contributions included:
• Hemophilia and the evolution of patient management
Sophie Susen
• Nanobodies and therapeutic antibodies: a revolution
Peter Lenting
• Gene therapy in hemophilia
Antoine Rauch
• Advances in other rare hemostatic disorders
Cécile Denis
A great recognition of the work carried out by UMR1011 – Team 2, with the active participation of Prof. sophie susen and Prof. Antoine Rauch, and of the strength of long-standing scientific collaborations with Cécile DENIS and Peter Lenting at UMR1176 HITh lab Inserm.
Missed the session?
The full recording is available on the Academy’s YouTube channel.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments